H6PD and neoplasm: Emerging evidence from in vitro and in vivo studies has demonstrated that inhibition of the rate-limiting enzyme G6PDH in PPP can strongly suppress tumor cell growth (Mele et al., 2018), suggesting that G6PDH may be a potential therapeutic target for exploring effective cancer treatment modalities (Pandolfi et al., 1995; Zhang et al., 2014).